About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Tata Group Pharma Firm Tie-up With Geneva-based DNDi for the Research of Kala-azar

by Medindia Content Team on October 12, 2007 at 4:13 PM
Font : A-A+

Tata Group Pharma Firm Tie-up With Geneva-based DNDi for the Research of Kala-azar

The Advinus Therapeutics (P) Ltd, a Tata Group pharmaceutical company based in Bangalore, has begun a partnership with the Geneva-based Drugs for Neglected Diseases initiative (DNDi) for discovery and development of therapies for visceral leishmaniasis, commonly known in India as Kala-azar.

Kala-azar is a fatal and infectious disease, which occurs in the developing world, including India and Africa. The collaboration is the first of its kind in India to find a therapy for the neglected disease.

Advertisement

Current treatments have significant drawbacks, either in terms of route of administration, length of treatment (21-28 days) or emerging parasitic resistance.

The collaboration, which will be for five years for now, brings together expertise in chemistry, biology, screening, and pre-formulation, and will help to strengthen capacity in Kala-azar endemic countries through training and networking.
Advertisement

The goal of the project is to find molecules proven to be safe and active against leishmania parasites in early stage and to screen research through the first steps of regulatory safety assessment in the pre-clinical phase, Advinus Therapeutics said in a release here Thursday.

"India today is one of the few countries in the world that not only has the disease burden, but also the capability and capacity to research and develop new therapies for these diseases," Rashmii Barbhaiya, CEO and MD of Advinus, said.

Bernard Pecoul of DNDi said the project should serve as a model for future drug development for neglected diseases.

The Drugs for Neglected Diseases initiative is a not-for-profit drug development initiative established in 2003 by five publicly funded research organisations - Malaysia's Ministry of Health, Kenya Medical Research Institute, Indian Council of Medical Research, Oswaldo Cruz Foundation Brazil, and the Institut Pasteur.

It is also supported by Médecins Sans Frontières and WHO's special programme for research and training in tropical diseases and is working on 18 healthcare research projects worldwide.

Source: IANS
VEN/C
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Cochlear Implants may Consequently Drive Hearing Loss
E-cigarettes Use Linked to Erectile Dysfunction
Memory Loss - Can it be Recovered?
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity 

Recommended Reading
Global Agencies Come Together to Eliminate Kala-azar in Bihar
US-based Bill and Melinda Gates Foundation, will work for the elimination of kala-azar, a deadly ......
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use